世界の同種異系幹細胞治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Allogeneic Stem Cell Therapy Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3781 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、同種異系幹細胞治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（成体幹細胞治療、ヒト胚性幹細胞治療、人工多能性幹細胞治療、その他）、用途別市場規模（筋骨格系障害、傷＆怪我、心血管疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・同種異系幹細胞治療の市場動向 ・企業の競争状況、市場シェア ・同種異系幹細胞治療の種類別市場規模と予測2016-2027（成体幹細胞治療、ヒト胚性幹細胞治療、人工多能性幹細胞治療、その他） ・同種異系幹細胞治療の用途別市場規模と予測2016-2027（筋骨格系障害、傷＆怪我、心血管疾患、その他） ・同種異系幹細胞治療の北米市場規模2016-2027（アメリカ、カナダ） ・同種異系幹細胞治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・同種異系幹細胞治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・同種異系幹細胞治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・同種異系幹細胞治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Escape Therapeutics, Inc.、Lonza Group Ltd.、Osiris Therapeutics (Smith & Nephew)、NuVasive、Chiesi Pharmaceuticals、JCR Pharmaceutical、Pharmicell、Anterogen、MolMed S.p.A.、Takeda (TiGenix)） ・結論

Market Analysis and Insights: Global Allogeneic Stem Cell Therapy Market
The global Allogeneic Stem Cell Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Allogeneic Stem Cell Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Allogeneic Stem Cell Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Allogeneic Stem Cell Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Allogeneic Stem Cell Therapy market.

Global Allogeneic Stem Cell Therapy Scope and Market Size
Allogeneic Stem Cell Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Allogeneic Stem Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Adult Stem Cell Therapy
Human Embryonic Stem Cell Therapy
Induced Pluripotent Stem Cell Therapy
Others

Segment by Application
Musculoskeletal Disorder
Wounds & Injuries
Cardiovascular Diseases
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Escape Therapeutics, Inc.
Lonza Group Ltd.
Osiris Therapeutics (Smith & Nephew)
NuVasive
Chiesi Pharmaceuticals
JCR Pharmaceutical
Pharmicell
Anterogen
MolMed S.p.A.
Takeda (TiGenix)

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Allogeneic Stem Cell Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Adult Stem Cell Therapy
1.2.3 Human Embryonic Stem Cell Therapy
1.2.4 Induced Pluripotent Stem Cell Therapy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Allogeneic Stem Cell Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Musculoskeletal Disorder
1.3.3 Wounds & Injuries
1.3.4 Cardiovascular Diseases
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Allogeneic Stem Cell Therapy Market Perspective (2016-2027)
2.2 Allogeneic Stem Cell Therapy Growth Trends by Regions
2.2.1 Allogeneic Stem Cell Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Allogeneic Stem Cell Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Allogeneic Stem Cell Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Allogeneic Stem Cell Therapy Industry Dynamic
2.3.1 Allogeneic Stem Cell Therapy Market Trends
2.3.2 Allogeneic Stem Cell Therapy Market Drivers
2.3.3 Allogeneic Stem Cell Therapy Market Challenges
2.3.4 Allogeneic Stem Cell Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Allogeneic Stem Cell Therapy Players by Revenue
3.1.1 Global Top Allogeneic Stem Cell Therapy Players by Revenue (2016-2021)
3.1.2 Global Allogeneic Stem Cell Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Allogeneic Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Allogeneic Stem Cell Therapy Revenue
3.4 Global Allogeneic Stem Cell Therapy Market Concentration Ratio
3.4.1 Global Allogeneic Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Allogeneic Stem Cell Therapy Revenue in 2020
3.5 Allogeneic Stem Cell Therapy Key Players Head office and Area Served
3.6 Key Players Allogeneic Stem Cell Therapy Product Solution and Service
3.7 Date of Enter into Allogeneic Stem Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Allogeneic Stem Cell Therapy Breakdown Data by Type
4.1 Global Allogeneic Stem Cell Therapy Historic Market Size by Type (2016-2021)
4.2 Global Allogeneic Stem Cell Therapy Forecasted Market Size by Type (2022-2027)

5 Allogeneic Stem Cell Therapy Breakdown Data by Application
5.1 Global Allogeneic Stem Cell Therapy Historic Market Size by Application (2016-2021)
5.2 Global Allogeneic Stem Cell Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Allogeneic Stem Cell Therapy Market Size (2016-2027)
6.2 North America Allogeneic Stem Cell Therapy Market Size by Type
6.2.1 North America Allogeneic Stem Cell Therapy Market Size by Type (2016-2021)
6.2.2 North America Allogeneic Stem Cell Therapy Market Size by Type (2022-2027)
6.2.3 North America Allogeneic Stem Cell Therapy Market Size by Type (2016-2027)
6.3 North America Allogeneic Stem Cell Therapy Market Size by Application
6.3.1 North America Allogeneic Stem Cell Therapy Market Size by Application (2016-2021)
6.3.2 North America Allogeneic Stem Cell Therapy Market Size by Application (2022-2027)
6.3.3 North America Allogeneic Stem Cell Therapy Market Size by Application (2016-2027)
6.4 North America Allogeneic Stem Cell Therapy Market Size by Country
6.4.1 North America Allogeneic Stem Cell Therapy Market Size by Country (2016-2021)
6.4.2 North America Allogeneic Stem Cell Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Allogeneic Stem Cell Therapy Market Size (2016-2027)
7.2 Europe Allogeneic Stem Cell Therapy Market Size by Type
7.2.1 Europe Allogeneic Stem Cell Therapy Market Size by Type (2016-2021)
7.2.2 Europe Allogeneic Stem Cell Therapy Market Size by Type (2022-2027)
7.2.3 Europe Allogeneic Stem Cell Therapy Market Size by Type (2016-2027)
7.3 Europe Allogeneic Stem Cell Therapy Market Size by Application
7.3.1 Europe Allogeneic Stem Cell Therapy Market Size by Application (2016-2021)
7.3.2 Europe Allogeneic Stem Cell Therapy Market Size by Application (2022-2027)
7.3.3 Europe Allogeneic Stem Cell Therapy Market Size by Application (2016-2027)
7.4 Europe Allogeneic Stem Cell Therapy Market Size by Country
7.4.1 Europe Allogeneic Stem Cell Therapy Market Size by Country (2016-2021)
7.4.2 Europe Allogeneic Stem Cell Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Allogeneic Stem Cell Therapy Market Size (2016-2027)
8.2 Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Type
8.2.1 Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Application
8.3.1 Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Region
8.4.1 Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Allogeneic Stem Cell Therapy Market Size (2016-2027)
9.2 Latin America Allogeneic Stem Cell Therapy Market Size by Type
9.2.1 Latin America Allogeneic Stem Cell Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Allogeneic Stem Cell Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Allogeneic Stem Cell Therapy Market Size by Type (2016-2027)
9.3 Latin America Allogeneic Stem Cell Therapy Market Size by Application
9.3.1 Latin America Allogeneic Stem Cell Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Allogeneic Stem Cell Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Allogeneic Stem Cell Therapy Market Size by Application (2016-2027)
9.4 Latin America Allogeneic Stem Cell Therapy Market Size by Country
9.4.1 Latin America Allogeneic Stem Cell Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Allogeneic Stem Cell Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Allogeneic Stem Cell Therapy Market Size (2016-2027)
10.2 Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Type
10.2.1 Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Application
10.3.1 Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Country
10.4.1 Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Escape Therapeutics, Inc.
11.1.1 Escape Therapeutics, Inc. Company Details
11.1.2 Escape Therapeutics, Inc. Business Overview
11.1.3 Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Introduction
11.1.4 Escape Therapeutics, Inc. Revenue in Allogeneic Stem Cell Therapy Business (2016-2021)
11.1.5 Escape Therapeutics, Inc. Recent Development
11.2 Lonza Group Ltd.
11.2.1 Lonza Group Ltd. Company Details
11.2.2 Lonza Group Ltd. Business Overview
11.2.3 Lonza Group Ltd. Allogeneic Stem Cell Therapy Introduction
11.2.4 Lonza Group Ltd. Revenue in Allogeneic Stem Cell Therapy Business (2016-2021)
11.2.5 Lonza Group Ltd. Recent Development
11.3 Osiris Therapeutics (Smith & Nephew)
11.3.1 Osiris Therapeutics (Smith & Nephew) Company Details
11.3.2 Osiris Therapeutics (Smith & Nephew) Business Overview
11.3.3 Osiris Therapeutics (Smith & Nephew) Allogeneic Stem Cell Therapy Introduction
11.3.4 Osiris Therapeutics (Smith & Nephew) Revenue in Allogeneic Stem Cell Therapy Business (2016-2021)
11.3.5 Osiris Therapeutics (Smith & Nephew) Recent Development
11.4 NuVasive
11.4.1 NuVasive Company Details
11.4.2 NuVasive Business Overview
11.4.3 NuVasive Allogeneic Stem Cell Therapy Introduction
11.4.4 NuVasive Revenue in Allogeneic Stem Cell Therapy Business (2016-2021)
11.4.5 NuVasive Recent Development
11.5 Chiesi Pharmaceuticals
11.5.1 Chiesi Pharmaceuticals Company Details
11.5.2 Chiesi Pharmaceuticals Business Overview
11.5.3 Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Introduction
11.5.4 Chiesi Pharmaceuticals Revenue in Allogeneic Stem Cell Therapy Business (2016-2021)
11.5.5 Chiesi Pharmaceuticals Recent Development
11.6 JCR Pharmaceutical
11.6.1 JCR Pharmaceutical Company Details
11.6.2 JCR Pharmaceutical Business Overview
11.6.3 JCR Pharmaceutical Allogeneic Stem Cell Therapy Introduction
11.6.4 JCR Pharmaceutical Revenue in Allogeneic Stem Cell Therapy Business (2016-2021)
11.6.5 JCR Pharmaceutical Recent Development
11.7 Pharmicell
11.7.1 Pharmicell Company Details
11.7.2 Pharmicell Business Overview
11.7.3 Pharmicell Allogeneic Stem Cell Therapy Introduction
11.7.4 Pharmicell Revenue in Allogeneic Stem Cell Therapy Business (2016-2021)
11.7.5 Pharmicell Recent Development
11.8 Anterogen
11.8.1 Anterogen Company Details
11.8.2 Anterogen Business Overview
11.8.3 Anterogen Allogeneic Stem Cell Therapy Introduction
11.8.4 Anterogen Revenue in Allogeneic Stem Cell Therapy Business (2016-2021)
11.8.5 Anterogen Recent Development
11.9 MolMed S.p.A.
11.9.1 MolMed S.p.A. Company Details
11.9.2 MolMed S.p.A. Business Overview
11.9.3 MolMed S.p.A. Allogeneic Stem Cell Therapy Introduction
11.9.4 MolMed S.p.A. Revenue in Allogeneic Stem Cell Therapy Business (2016-2021)
11.9.5 MolMed S.p.A. Recent Development
11.10 Takeda (TiGenix)
11.10.1 Takeda (TiGenix) Company Details
11.10.2 Takeda (TiGenix) Business Overview
11.10.3 Takeda (TiGenix) Allogeneic Stem Cell Therapy Introduction
11.10.4 Takeda (TiGenix) Revenue in Allogeneic Stem Cell Therapy Business (2016-2021)
11.10.5 Takeda (TiGenix) Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Allogeneic Stem Cell Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Adult Stem Cell Therapy
Table 3. Key Players of Human Embryonic Stem Cell Therapy
Table 4. Key Players of Induced Pluripotent Stem Cell Therapy
Table 5. Key Players of Others
Table 6. Global Allogeneic Stem Cell Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Allogeneic Stem Cell Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Allogeneic Stem Cell Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Allogeneic Stem Cell Therapy Market Share by Regions (2016-2021)
Table 10. Global Allogeneic Stem Cell Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Allogeneic Stem Cell Therapy Market Share by Regions (2022-2027)
Table 12. Allogeneic Stem Cell Therapy Market Trends
Table 13. Allogeneic Stem Cell Therapy Market Drivers
Table 14. Allogeneic Stem Cell Therapy Market Challenges
Table 15. Allogeneic Stem Cell Therapy Market Restraints
Table 16. Global Allogeneic Stem Cell Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Allogeneic Stem Cell Therapy Market Share by Players (2016-2021)
Table 18. Global Top Allogeneic Stem Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Allogeneic Stem Cell Therapy as of 2020)
Table 19. Ranking of Global Top Allogeneic Stem Cell Therapy Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Allogeneic Stem Cell Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Allogeneic Stem Cell Therapy Product Solution and Service
Table 23. Date of Enter into Allogeneic Stem Cell Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Allogeneic Stem Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Allogeneic Stem Cell Therapy Revenue Market Share by Type (2016-2021)
Table 27. Global Allogeneic Stem Cell Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Allogeneic Stem Cell Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Allogeneic Stem Cell Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Allogeneic Stem Cell Therapy Revenue Market Share by Application (2016-2021)
Table 31. Global Allogeneic Stem Cell Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Allogeneic Stem Cell Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Allogeneic Stem Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Allogeneic Stem Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Allogeneic Stem Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Allogeneic Stem Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Allogeneic Stem Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Allogeneic Stem Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Allogeneic Stem Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Allogeneic Stem Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Allogeneic Stem Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Allogeneic Stem Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Allogeneic Stem Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Allogeneic Stem Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Allogeneic Stem Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Allogeneic Stem Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Allogeneic Stem Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Allogeneic Stem Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Allogeneic Stem Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Allogeneic Stem Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 63. Escape Therapeutics, Inc. Company Details
Table 64. Escape Therapeutics, Inc. Business Overview
Table 65. Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Product
Table 66. Escape Therapeutics, Inc. Revenue in Allogeneic Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 67. Escape Therapeutics, Inc. Recent Development
Table 68. Lonza Group Ltd. Company Details
Table 69. Lonza Group Ltd. Business Overview
Table 70. Lonza Group Ltd. Allogeneic Stem Cell Therapy Product
Table 71. Lonza Group Ltd. Revenue in Allogeneic Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 72. Lonza Group Ltd. Recent Development
Table 73. Osiris Therapeutics (Smith & Nephew) Company Details
Table 74. Osiris Therapeutics (Smith & Nephew) Business Overview
Table 75. Osiris Therapeutics (Smith & Nephew) Allogeneic Stem Cell Therapy Product
Table 76. Osiris Therapeutics (Smith & Nephew) Revenue in Allogeneic Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 77. Osiris Therapeutics (Smith & Nephew) Recent Development
Table 78. NuVasive Company Details
Table 79. NuVasive Business Overview
Table 80. NuVasive Allogeneic Stem Cell Therapy Product
Table 81. NuVasive Revenue in Allogeneic Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 82. NuVasive Recent Development
Table 83. Chiesi Pharmaceuticals Company Details
Table 84. Chiesi Pharmaceuticals Business Overview
Table 85. Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Product
Table 86. Chiesi Pharmaceuticals Revenue in Allogeneic Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 87. Chiesi Pharmaceuticals Recent Development
Table 88. JCR Pharmaceutical Company Details
Table 89. JCR Pharmaceutical Business Overview
Table 90. JCR Pharmaceutical Allogeneic Stem Cell Therapy Product
Table 91. JCR Pharmaceutical Revenue in Allogeneic Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 92. JCR Pharmaceutical Recent Development
Table 93. Pharmicell Company Details
Table 94. Pharmicell Business Overview
Table 95. Pharmicell Allogeneic Stem Cell Therapy Product
Table 96. Pharmicell Revenue in Allogeneic Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 97. Pharmicell Recent Development
Table 98. Anterogen Company Details
Table 99. Anterogen Business Overview
Table 100. Anterogen Revenue in Allogeneic Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 101. Anterogen Recent Development
Table 102. MolMed S.p.A. Company Details
Table 103. MolMed S.p.A. Business Overview
Table 104. MolMed S.p.A. Allogeneic Stem Cell Therapy Product
Table 105. MolMed S.p.A. Revenue in Allogeneic Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 106. MolMed S.p.A. Recent Development
Table 107. Takeda (TiGenix) Company Details
Table 108. Takeda (TiGenix) Business Overview
Table 109. Takeda (TiGenix) Allogeneic Stem Cell Therapy Product
Table 110. Takeda (TiGenix) Revenue in Allogeneic Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 111. Takeda (TiGenix) Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Allogeneic Stem Cell Therapy Market Share by Type: 2020 VS 2027
Figure 2. Adult Stem Cell Therapy Features
Figure 3. Human Embryonic Stem Cell Therapy Features
Figure 4. Induced Pluripotent Stem Cell Therapy Features
Figure 5. Others Features
Figure 6. Global Allogeneic Stem Cell Therapy Market Share by Application: 2020 VS 2027
Figure 7. Musculoskeletal Disorder Case Studies
Figure 8. Wounds & Injuries Case Studies
Figure 9. Cardiovascular Diseases Case Studies
Figure 10. Others Case Studies
Figure 11. Allogeneic Stem Cell Therapy Report Years Considered
Figure 12. Global Allogeneic Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Allogeneic Stem Cell Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Allogeneic Stem Cell Therapy Market Share by Regions: 2020 VS 2027
Figure 15. Global Allogeneic Stem Cell Therapy Market Share by Regions (2022-2027)
Figure 16. Global Allogeneic Stem Cell Therapy Market Share by Players in 2020
Figure 17. Global Top Allogeneic Stem Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Allogeneic Stem Cell Therapy as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Allogeneic Stem Cell Therapy Revenue in 2020
Figure 19. Global Allogeneic Stem Cell Therapy Revenue Market Share by Type (2016-2021)
Figure 20. Global Allogeneic Stem Cell Therapy Revenue Market Share by Type (2022-2027)
Figure 21. North America Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Allogeneic Stem Cell Therapy Market Share by Type (2016-2027)
Figure 23. North America Allogeneic Stem Cell Therapy Market Share by Application (2016-2027)
Figure 24. North America Allogeneic Stem Cell Therapy Market Share by Country (2016-2027)
Figure 25. United States Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Allogeneic Stem Cell Therapy Market Share by Type (2016-2027)
Figure 29. Europe Allogeneic Stem Cell Therapy Market Share by Application (2016-2027)
Figure 30. Europe Allogeneic Stem Cell Therapy Market Share by Country (2016-2027)
Figure 31. Germany Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Allogeneic Stem Cell Therapy Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Allogeneic Stem Cell Therapy Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Allogeneic Stem Cell Therapy Market Share by Region (2016-2027)
Figure 41. China Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Allogeneic Stem Cell Therapy Market Share by Type (2016-2027)
Figure 49. Latin America Allogeneic Stem Cell Therapy Market Share by Application (2016-2027)
Figure 50. Latin America Allogeneic Stem Cell Therapy Market Share by Country (2016-2027)
Figure 51. Mexico Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Allogeneic Stem Cell Therapy Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Allogeneic Stem Cell Therapy Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Allogeneic Stem Cell Therapy Market Share by Country (2016-2027)
Figure 57. Turkey Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Escape Therapeutics, Inc. Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2016-2021)
Figure 61. Lonza Group Ltd. Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2016-2021)
Figure 62. Osiris Therapeutics (Smith & Nephew) Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2016-2021)
Figure 63. NuVasive Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2016-2021)
Figure 64. Chiesi Pharmaceuticals Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2016-2021)
Figure 65. JCR Pharmaceutical Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2016-2021)
Figure 66. Pharmicell Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2016-2021)
Figure 67. Anterogen Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2016-2021)
Figure 68. MolMed S.p.A. Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2016-2021)
Figure 69. Takeda (TiGenix) Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---